AstraZeneca CEO celebrates 1st anniversary with promising lung cancer data – FierceBiotech

by lowes1 on September 30, 2013

AstraZeneca CEO celebrates 1st anniversary with promising lung cancer data
FierceBiotech
Investigators unveiled a promising early-stage look at its lung cancer drug, AZD9291, which inspired Leerink Swann's Seamus Fernandez to enthuse about its blockbuster potential and add $500 million to his peak sales model for the drug. And AstraZeneca 

and more »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: